This narrative review looks at human parainfluenza virus infections in specific groups. The focus is on infants, the elderly, immunocompromised individuals, and children under five. The authors examine host factors that influence viral entry, replication, assembly, release, and innate immunity evasion. This review aims to accelerate the development of innovative host-directed therapies for these conditions.
The study does not report a specific sample size or follow-up period. It is a narrative review, which means it summarizes existing knowledge rather than presenting new clinical trial data. No specific medications were tested in this analysis.
Safety concerns were not reported in this review. The main reason to be careful is that this is a narrative review, not a clinical trial. Readers should understand that this information helps guide future research into host-directed therapies rather than providing immediate treatment options for acute respiratory infections.